EGFR and non-small cell lung carcinoma: A study by Xiang et al identified 38 irreversible EGFR‐T790M inhibitors using this strategy.148, 149 One more study developed a computational model based on chemical‐/protein‐chemical interaction and identified molecules with anti‐NSCLC activity.150